Anizatrectinib
Anizatrectinib (hTrkA-IN-1) is a potent and orally active inhibitor of TrkA kinase with an IC50 of 1.3 nM, compound 2 extracted from patent WO2015175788. Anizatrectinib can be used for the study of inflammatory disease, such as prostatitis, pelvic, et al.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1824664-89-2
- Formule: C29H32FN7O2
- Masse moléculaire:529.61
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
TrkA |
Chemical Information
-
CAS No. 1824664-89-2
-
Masse moléculaire 529.61
-
Formule C29H32FN7O2
-
SMILES
O=C(NC1=C(C)C(C2=CN=C(C)N=C2)=NN1C3=CC=CC=C3)N[C@@H]4CN(CCOC)C[C@H]4C5=CC=CC(F)=C5
-
Synonyms
hTrkA-IN-1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)